Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.
Munoz L, Ranaivo HR, Roy SM, Hu W, Craft JM, McNamara LK, Chico LW, Van Eldik LJ, Watterson DM
J Neuroinflammation 2007, 4:21
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Review    
The p38 mitogen-activated protein kinase as a central nervous system drug discovery target
Borders AS, de Almeida L, Van Eldik LJ, Watterson DM
BMC Neuroscience 2008, 9(Suppl 2):S12 (3 December 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Research    
Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury
Lloyd E, Somera-Molina K, Van Eldik LJ, Watterson DM, Wainwright MS
Journal of Neuroinflammation 2008, 5:28 (30 June 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.


Research    
Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid
Nichol KE, Poon WW, Parachikova AI, Cribbs DH, Glabe CG, Cotman CW
Journal of Neuroinflammation 2008, 5:13 (9 April 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 2 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.